Related to Medicago Achieves Fourth Milestone in Setting Up U.S. cGMP Facility for Plant-Expressed Vaccines

• XSPray Opens GMP Plant for Particulate Drug Manufacturing
  
• Clinical Reference Sets Up U.K. Lab along with Quotient Bioresearch
  
• GenVec Obtains $2.5M to Enhance Vector Production Technology
  
• Sinovac to Supply Flu Vaccine to Beijing Citizens
  
• Genentech to Buy Lonza-Built Biologics Production Site in Singapore for $290M
  
• Scientists Use C. Crescentus to Make Proteins
  
• FDA Lifts Hold on Dynavax’ Phase III HBV Vaccine
  
• Millipore and Roka Bioscience to Develop Molecular Tests for Biopharmaceutical Manufacturing
  
• PPD Opens Lab in Singapore to Support Demand in Southeast Asia
  
• FDA Okays Vaccines for 2009 H1N1 Influenza Virus
  
• Wellcome Trust and Merck Set Up JV to Focus on Vaccines for Developing Nations
  
• Antigen Discovery Scores $1.8M from NIAID to Develop Chlamydia Vaccine
  
• Nycomed to Invest At Least $96M for a Manufacturing Facility in Russia
  
• China Biologic Allies with Chinese Institute to Improve Production of Plasma-Based Products
  
• FDA Awards Biosearch $3.4M for Surveillance Methods to Be Used in Pathogen Detection
  
• AVI BioPharma Obtains Expanded DoD Contract Worth $11.5M for Its Junin Virus Infection Treatment
  
• GSK Furthers Interest in China through Pediatric Vaccines JV with Initial $32M Investment
  
• Fast EU Approval of Baxter’s H1N1 Flu Vaccine Enabled by EMEA’s Mock-Up Licensure Process
  
• Neumedicines Obtains $4.9M to Support Development of Preclinical Radiomitigator
  
• UAB Wins $11.5M Grant to Advance R&D on HPV Vaccines